A critical breakthrough in cancer investigation is arising with the use of VHH fragments to reactivate mutated p53. This vital cancer inhibitor protein is frequently disabled in several types of malignancies, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research